⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 12, 2024Open Access

Figure S5 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Ignacio Campillo‐Marcos Marta Casado-Peláez Verónica Dávalos Gerardo Ferrer Caterina Mata Elisabetta Mereu Gaël Roué David Valcárcel Antonieta Molero Lurdes Zamora Blanca Xicoy Laura Palomo Pamela Acha Ana Manzanares Magnus Tobiasson Eva Hellström‐Lindberg Françesc Solé Manel Esteller

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Impact of AZA treatment on cell populations according to response status

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Campillo‐Marcos et al. (2024) studied this question.

synapsesocial.com/papers/68e79960b6db64358770930b https://doi.org/10.1158/2767-9764.25206443.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S10 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
2Figure S11 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
3Figure S6 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
4FIGURE 6 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
5FIGURE 3 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024

More related papers

FIGURE 4 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
FIGURE 1 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
Figure S4 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024